相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force
P. S. Aisen et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials
Alette M. Wessels et al.
JAMA NEUROLOGY (2020)
Biological subtypes of Alzheimer disease A systematic review and meta-analysis
Daniel Ferreira et al.
NEUROLOGY (2020)
Futility Analyses in Alzheimer's Disease (AD) Clinical Trials: A Risky Business
P. S. Aisen et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2020)
The Role of Futility Analyses in Alzheimer's Disease Clinical Trials
Rachelle Doody
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2020)
The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years
S. Walter et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2020)
Assessing research participant preferences for receiving study results
Sarah Cook et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2020)
From Victimhood to Warriors: Super-researchers' Insights Into Alzheimer's Disease Clinical Trial Participation Motivations
Shoshana H. Bardach et al.
GERONTOLOGIST (2020)
The Future of Anti-Amyloid Trials
P. S. Aisen et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2020)
The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0
Craig William Ritchie et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2020)
Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease
David Henley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease
James A. R. Nicoll et al.
BRAIN (2019)
Open science: The open clinical trials data journey
Frank Rockhold et al.
CLINICAL TRIALS (2019)
Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysis
Aaron Dane et al.
PHARMACEUTICAL STATISTICS (2019)
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
Konstantina G. Yiannopoulou et al.
BIOMEDICINES (2019)
Sense of Self in Alzheimer's Research Participants
Ragnhild Hedman et al.
CLINICAL NURSING RESEARCH (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
David M. Kent et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Overview and experience of the YODA Project with clinical trial data sharing after 5 years
Joseph S. Ross et al.
SCIENTIFIC DATA (2018)
Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes
Jeffrey Cummings
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials
Ilya Lipkovich et al.
STATISTICS IN MEDICINE (2017)
Why do so many clinical trials of therapies for Alzheimer's disease fail?
Roy M. Anderson et al.
LANCET (2017)
Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials
Stacie Weninger et al.
Alzheimers & Dementia (2016)
Communicating with participants during the conduct of multi-center clinical trials
Erika F. Augustine et al.
CLINICAL TRIALS (2016)
A Global, Neutral Platform for Sharing Trial Data
Barbara E. Bierer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Future Is Now: Model-Based Clinical Trial Design for Alzheimer's Disease
K. Romero et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Economic analysis of opportunities to accelerate Alzheimer's disease research and development
Troy J. Scott et al.
ANNALS REPORTS (2014)
Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
Bruno Vellas et al.
ALZHEIMERS & DEMENTIA (2013)
Adaptive enrichment designs for clinical trials
Noah Simon et al.
BIOSTATISTICS (2013)
Once Bitten, Twice Shy: Participant perspectives in the aftermath of an early HIV vaccine trial termination
P. A. Newman et al.
VACCINE (2011)
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
Joshua D. Grill et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Bruno Vellas et al.
CURRENT ALZHEIMER RESEARCH (2009)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?
M Mastwyk et al.
INTERNATIONAL PSYCHOGERIATRICS (2003)
What makes clinical research ethical?
EJ Emanuel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
